The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis

Davies G., Wells A. U., Doffman S., Watanabe S., Wilson R.

Source: Eur Respir J 2006; 28: 974-979
Journal Issue: November
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Davies G., Wells A. U., Doffman S., Watanabe S., Wilson R.. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 2006; 28: 974-979

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pseudomonas aeruginosa as an independent predictor of decreased lung function in bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018

Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005



Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017




Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006



Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007



Bacterial cyanogenesis occurs in the cystic fibrosis lung
Source: Eur Respir J 2008; 32: 329-333
Year: 2008



Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003



Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008



Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006


Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004



Mucoid Pseudomonas aeruginosa alter sputum viscoelastic properties in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019


Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients?
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018



Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Source: Eur Respir J 2005; 25: 474-481
Year: 2005



Pulmonary infections with pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004